Biocorrx (OTCMKTS:BICX) vs. Auna (NYSE:AUNA) Head to Head Survey

Auna (NYSE:AUNA) and Biocorrx (OTCMKTS:BICX) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, institutional ownership, dividends and analyst recommendations.

Analyst Ratings

This is a summary of current ratings for Auna and Biocorrx, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Auna	1	2	1	1	2.40
Biocorrx	0	1	0	0	2.00

Auna currently has a consensus price target of $6.97, indicating a potential upside of 33.97%. Given Auna’s stronger consensus rating and higher probable upside, research analysts plainly believe Auna is more favorable than Biocorrx.

Earnings & Valuation

This table compares Auna and Biocorrx”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Auna	$4.52 billion	0.09	$27.39 million	$0.26	20.00
Biocorrx	$800,000.00	11.05	-$3.44 million	($0.16)	-1.86

Auna has higher revenue and earnings than Biocorrx. Biocorrx is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Auna has a beta of 0.61, meaning that its stock price is 39% less volatile than the S&P 500. Comparatively, Biocorrx has a beta of 0.19, meaning that its stock price is 81% less volatile than the S&P 500.

Profitability

This table compares Auna and Biocorrx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Auna	1.53%	16.25%	4.03%
Biocorrx	N/A	N/A	-73.40%

Summary

Auna beats Biocorrx on 12 of the 13 factors compared between the two stocks.

About Auna

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.

About Biocorrx

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.